Deferred Tax Assets, Valuation Allowance of X4 Pharmaceuticals, Inc from 31 Dec 2015 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
X4 Pharmaceuticals, Inc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2024.
  • X4 Pharmaceuticals, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $184,908,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

X4 Pharmaceuticals, Inc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $184,908,000 +$20,914,000 +13% 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q4 2023 $163,994,000 +$30,882,000 +23% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q4 2022 $133,112,000 +$21,277,000 +19% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $111,835,000 +$19,638,000 +21% 31 Dec 2021 10-K 21 Mar 2023 2022 FY
Q4 2020 $92,197,000 +$18,787,000 +26% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 $73,410,000 +$50,613,000 +222% 31 Dec 2019 10-K 19 Mar 2021 2020 FY
Q4 2018 $22,797,000 -$2,936,000 -11% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q4 2017 $25,733,000 +$7,729,000 +43% 31 Dec 2017 10-K 11 Mar 2019 2018 FY
Q4 2016 $18,004,000 +$7,637,000 +74% 31 Dec 2016 10-K 11 Mar 2019 2018 FY
Q4 2015 $10,367,000 31 Dec 2015 10-K 11 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.